Eikon Therapeutics | 29,524 followers on LinkedIn. Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and developing breakthrough therapeutics | Eikon Therapeutics is a late-stage clinical biopharmaceutical company advancing a pipeline of potential therapies for patients with unmet medical needs. We are passionate about novel therapeutics and share the belief that a better understanding of fundamental human disease biology can lead to better medicines. We are driven to go beyond incremental improvements.